• 免費註冊
  • 加入官方line@
  • 加入FB粉絲團

台股 » 個股 » 健亞 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

健亞

(4130)
可現股當沖
  • 股價
    23.90
  • 漲跌
    ▼0.05
  • 漲幅
    -0.21%
  • 成交量
    335張
  • 產業
    上櫃 生技醫療類股

  • 151人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
健亞 (4130)籌碼相關－高橋-內壢 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效，來找出真正獲利的贏家所在券商分點，進而追蹤此贏家所操作的股票與軌跡。

股票投資新手教室：一秒知道是否上對大戶列車

高橋-內壢 券商分點個股進出

高橋-內壢 券商分點全部個股操作績效/獲利分析

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/201124.23624.4223.7052831.76%
2025/01/171325.24125.4025.20122544.72%
2025/01/16224.28424.7625.30-2225-0.89%
2025/01/151.924.52325.0024.85-1.1187-0.58%
2025/01/1400.00922.8422.95-9104-8.61%
2025/01/13221.10221.7520.900870.00%
2025/01/10221.131021.4421.15-886-9.22%
2025/01/09520.8900.0020.855845.92%
2025/01/08220.8500.0020.852832.39%
2025/01/03120.7500.0020.701861.16%
2024/12/30120.9000.0020.901881.12%
2024/12/2600.00321.2321.15-393-3.20%
2024/12/25120.7000.0020.701931.07%
2024/12/2400.00121.0520.80-195-1.05%
2024/12/23120.7500.0020.701951.05%
2024/12/06121.8000.0021.801981.01%
2024/12/05121.9000.0021.851971.02%
2024/11/2900.00121.9521.85-199-1.00%
2024/11/26121.8000.0021.8511001.00%
2024/11/22121.9000.0021.8011010.99%
2024/11/21121.90021.9521.9511020.94%
2024/11/1900.00121.9521.95-1104-0.96%
2024/11/1800.00121.9521.75-1108-0.92%
2024/11/1500.00222.0321.90-2108-1.84%
2024/11/07322.3800.0022.3531112.70%
2024/10/29122.4000.0022.4511410.71%
2024/10/28222.48122.8022.5511420.70%
2024/10/25422.4900.0022.4041442.76%
2024/10/24122.6500.0022.7011460.68%
2024/10/23122.80322.8822.80-2148-1.34%
2024/10/2200.00122.6022.45-1146-0.68%
2024/10/1600.000.122.3022.15-0.1160-0.06%
2024/10/09222.4800.0022.4021691.18%
2024/10/08222.9000.0022.7521691.18%
2024/10/0400.00223.1323.20-2178-1.12%
2024/10/01322.93123.0523.0021781.12%
2024/09/2600.00122.8522.75-1180-0.55%
2024/09/2300.00322.6222.65-3188-1.59%
2024/09/1900.00122.3522.30-1193-0.52%
2024/09/1800.00422.2822.05-4195-2.04%
2024/09/1600.00222.0021.95-2197-1.01%
2024/09/1300.00121.9021.85-1198-0.50%
2024/09/1200.00121.8021.80-1201-0.50%
2024/09/11121.50121.7021.5502020.00%
2024/09/10221.63221.8321.6002040.00%
2024/09/09321.7200.0021.5032051.46%
2024/09/0600.00222.2522.20-2203-0.98%
2024/09/04221.9500.0021.9022080.96%
2024/09/03122.30122.4522.2502090.00%
2024/09/02322.2200.0022.1032081.44%
2024/08/30122.65122.8522.6502090.00%
2024/08/2900.00122.6522.60-1208-0.48%
2024/08/2800.00122.5522.55-1210-0.47%
2024/08/26122.30122.3522.4002130.00%
2024/08/23222.25122.4022.3512150.46%
2024/08/22422.4100.0022.3542151.85%
2024/08/21122.40122.6522.4002200.00%
2024/08/20122.95423.3423.40-3219-1.37%
2024/08/1600.00122.8022.75-1217-0.46%
2024/08/13122.4500.0022.4012240.44%
2024/08/09222.6300.0022.5522240.89%
2024/08/0800.00122.7022.60-1226-0.44%
2024/08/07122.35122.1522.3502260.00%
2024/08/06221.3800.0021.3522240.89%
2024/08/05221.60421.8421.65-2221-0.90%
2024/08/01223.0500.0023.2022120.94%
2024/07/26323.3700.0023.2532141.40%
2024/07/2300.00123.7523.65-1213-0.47%
2024/07/22323.4500.0023.4032141.40%
2024/07/19124.1000.0023.9012110.47%
2024/07/1800.00424.3624.40-4209-1.91%
2024/07/16124.15124.4024.2002050.00%
2024/07/1500.00124.2524.20-1206-0.49%
2024/07/11124.1000.0024.0512050.49%
2024/07/10124.1500.0024.3012070.48%
2024/07/09224.2300.0024.0522080.96%
2024/07/08124.5500.0024.6012040.49%
2024/07/05124.65124.8524.7502060.00%
2024/07/04124.5000.0024.6012070.48%
2024/06/2600.00124.8524.65-1195-0.51%
2024/06/2400.00324.7524.55-3192-1.56%
2024/06/20124.40124.6524.4001900.00%
2024/06/19224.4300.0024.3521901.05%
2024/06/1700.00124.8024.80-1190-0.52%
2024/06/1400.00124.6024.65-1188-0.53%
2024/06/12124.3000.0024.3011890.53%
2024/06/11124.40224.6024.55-1189-0.53%
2024/06/06224.2500.0024.2521911.04%
2024/06/05224.05724.3224.35-5193-2.59%
2024/06/03024.15324.2524.25-3200-1.49%
2024/05/3100.00324.0524.05-3201-1.49%
2024/05/29124.0000.0024.1012010.50%
2024/05/28124.10124.3024.2502050.00%
2024/05/272.124.0200.0023.952.12041.01%
2024/05/240.323.9200.0024.000.32010.16%
2024/05/230.124.0500.0023.950.12040.05%
2024/05/222.524.1100.0024.102.52061.21%
2024/05/21124.1500.0024.1512190.46%
2024/05/2000.00124.5524.40-1220-0.45%
2024/05/03124.1500.0024.0512200.45%
2024/05/02124.3000.0024.4512170.46%
2024/04/12124.9000.0024.9512150.46%
2024/04/11125.1000.0025.0512130.47%
2024/04/1000.00125.3025.30-1213-0.47%
2024/04/09125.0500.0025.0512130.47%
2024/03/28125.00125.2525.0502240.00%
2024/03/2200.00124.8524.90-1227-0.44%
2024/03/15125.0500.0025.1012330.43%
2024/03/1400.00125.3525.20-1234-0.43%
2024/03/13125.15125.5025.1502360.00%
2024/03/08125.05125.5525.0502410.00%
2024/03/05225.8000.0025.7522460.81%
2024/03/0100.00226.1026.30-2256-0.78%
2024/02/2700.00125.9525.80-1272-0.37%
2024/02/23225.7500.0025.6022730.73%
2024/02/2200.00226.0826.10-2271-0.74%
2024/02/21125.65125.9525.6002590.00%
2024/02/15125.20325.3225.35-2257-0.78%
2024/02/05124.7000.0024.3512540.39%
新藥研發 浩鼎子公司抗癌新藥申請一期臨床 健亞明年完成試驗Anue鉅亨－2022/09/12
...詳全文
健亞轉投資浩宇超音波D針具追蹤系統 獲美台上市許可UDN聯合新聞網－2022/05/09
健亞（4130）今（9）日宣布，轉投資浩宇生醫公司開發的NAVIRFA（納維爾）超音波3D手術針具追蹤系統，雙雙取得美、......詳全文
健亞轉拓資浩宇NaviFUS®產品 首獲研究用途設備訂單UDN聯合新聞網－2021/03/15
健亞（4130）今（15）日宣布，轉投資的浩宇生醫，下半年將取得肝癌治療產品NAVIRFA®之美國510（k）及台灣二類......詳全文
健亞 相關文章